HealthEquity, Inc. $HQY Shares Acquired by Janus Henderson Group PLC

Janus Henderson Group PLC increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 850,411 shares of the company’s stock after buying an additional 30,178 shares during the period. Janus Henderson Group PLC’s holdings in HealthEquity were worth $71,068,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC boosted its position in HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after buying an additional 116 shares during the last quarter. Truist Financial Corp increased its position in shares of HealthEquity by 4.9% during the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after acquiring an additional 119 shares during the last quarter. Fiduciary Trust Co increased its position in shares of HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares during the last quarter. Larson Financial Group LLC lifted its stake in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares in the last quarter. Finally, Merit Financial Group LLC lifted its stake in shares of HealthEquity by 8.9% in the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after acquiring an additional 172 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Trading Down 0.4%

Shares of NASDAQ HQY opened at $100.61 on Friday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock’s 50 day moving average price is $91.74 and its two-hundred day moving average price is $85.12. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96. The stock has a market capitalization of $8.41 billion, a P/E ratio of 37.68, a PEG ratio of 1.69 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This represents a 7.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 17,905 shares of company stock worth $1,651,280 over the last ninety days. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on HQY. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. BTIG Research upped their target price on HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Friday, July 24th. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and increased their target price for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research report on Monday, June 1st. Finally, Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Eleven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.